MHC/peptide tetramer-based studies of T cell function

Journal of Immunological Methods

Volumn 268, Issue 1, 2002, Pages 21-28

  Xu, Xiao Ning ^a   Screaton, Gavin R ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Apoptosis; CTL; Tetramer; Tumour

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; FAS LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE DERIVATIVE; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANTIGEN SPECIFICITY; APOPTOSIS; CELL CULTURE; CYTOTOXIC T LYMPHOCYTE; GRAFT REJECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOTHERAPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REVIEW; T LYMPHOCYTE ACTIVATION;

ANIMALIA;

EID: 0036800935     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(02)00196-5     Document Type: Article

References (20)

1. Aichele P., Brduscha-Riem K., Oehen S., Odermatt B., Zinkernagel R.M., Hengartner H., Pircher H. Peptide antigen treatment of naive and virus-immune mice: antigen-specific tolerance versus immunopathology. Immunity. 6:1997;519.
2. Altman J.D., Moss P.A.H., Goulder P.J.R., Barouch D.H., McHeyzer-Williams M.G., Bell J.I., McMichael A.J., Davis M.M. Phenotypic analysis of antigen-specific T lymphocytes. Science. 274:1996;94.
3. Appay V., Nixon D.F., Donahoe S.M., Gillespie G.M., Dong T., King A., Ogg G.S., Spiegel H.M., Conlon C., Spina C.A., Havlir D.V., Richman D.D., Waters A., Easterbrook P., McMichael A.J., Rowland-Jones S.L. HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J. Exp. Med. 192:2000;63.
4. Boniface J.J., Rabinowitz J.D., Wulfing C., Hampl J., Reich Z., Altman J.D., Kantor R.M., Beeson C., McConnell H.M., Davis M.M. Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands. Immunity. 9:1998;459.
5. Combadiere B., Sousa C.R., Trageser C., Zheng L.X., Kim C.R., Lenardo M.J. Differential TCR signaling regulates apoptosis and immunopathology during antigen responses in vivo. Immunity. 9:1998;305.
6. Dunbar P.R., Ogg G.S., Chen J., Rust N., van der Bruggen P., Cerundolo V. Direct isolation, phenotyping and cloning of low-frequency antigen-specific cytotoxic T lymphocytes from peripheral blood. Curr. Biol. 8:1998;413.
7. Grakoui A., Bromley S.K., Sumen C., Davis M.M., Shaw A.S., Allen P.M., Dustin M.L. The immunological synapse: a molecular machine controlling T cell activation. Science. 285:1999;221.
8. Guo Y.J., Che X.Y., Shen F., Xie T.P., Ma J., Wang X.N., Wu S.G., Anthony D.D., Wu M.C. Effective tumor vaccines generated by in vitro modification of tumor cells with cytokines and bispecific monoclonal antibodies. Nat. Med. 3:1997;451.
9. Lenardo M., Chan K.M., Hornung F., McFarland H., Siegel R., Wang J., Zheng L. Mature T lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigenic environment. Annu. Rev. Immunol. 17:1999;221.
10. Levy R. A perspective on monoclonal antibody therapy: where we have been and where we are going. Semin. Hematol. 37:2000;43.
11. Maile R., Wang B., Schooler W., Meyer A., Collins E.J., Frelinger J.A. Antigen-specific modulation of an immune response by in vivo administration of soluble MHC class I tetramers. J. Immunol. 167:2001;3708.
12. Ogg G.S., Dunbar P.R., Cerundolo V., McMichael A.J., Lemoine N.R., Savage P. Sensitization of tumour cells to lysis by virus-specific CTL using antibody-targeted MHC class I/peptide complexes. Br. J. Cancer. 82:2000;1058.
13. O'Herrin S.M., Slansky J.E., Tang Q., Markiewicz M.A., Gajewski T.F., Pardoll D.M., Schneck J.P., Bluestone J.A. Antigen-specific blockade of t cells in vivo using dimeric MHC peptide. J. Immunol. 167:2001;2555.
14. Purbhoo M.A., Boulter J.M., Price D.A., Vuidepot A.L., Hourigan C.S., Dunbar P.R., Olson K., Dawson S.J., Phillips R.E., Jakobsen B.K., Bell J.I., Sewell A.K. The human CD8 coreceptor effects cytotoxic T cell activation and antigen sensitivity primarily by mediating complete phosphorylation of the T cell receptor zeta chain. J. Biol. Chem. 276:2001;32786.
15. Riethmuller G., Johnson J.P. Monoclonal antibodies in the detection and therapy of micrometastatic epithelial cancers. Curr. Opin. Immunol. 4:1992;647.
16. Robert B., Guillaume P., Luescher I., Romero P., Mach J.P. Antibody-conjugated MHC class I tetramers can target tumor cells for specific lysis by T lymphocytes. Eur. J. Immunol. 30:2000;3165.
17. Romero P., Dunbar P.R., Valmori D., Pittet M., Ogg G.S., Rimoldi D., Chen J.L., Lienard D., Cerottini J.C., Cerundolo V. Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes. J. Exp. Med. 188:1998;1641.
18. Valitutti S., Muller S., Cella M., Padovan E., Lanzavecchia A. Serial triggering of many T cell receptors by a few peptide-MHC complexes. Nature. 375:1995;148.
19. Wang M., Stepkowski S.M., Wang M.E., Tian L., Qu X., Tu Y., He G., Kahan B.D. Induction of specific allograft immunity by soluble class I MHC heavy chain protein produced in a baculovirus expression system. Transplantation. 61:1996;448.
20. Xu X.N., Purbhoo M.A., Chen N., Mongkolsapaya J., Cox J.H., Meier U.C., Tafuro S., Dunbar P.R., Sewell A.K., Hourigan C.S., Appay V., Cerundolo V., Burrows S.R., McMichael A.J., Screaton G.R. A novel approach to antigen-specific deletion of CTL with minimal cellular activation using alpha3 domain mutants of MHC class I/peptide complex. Immunity. 14:2001;591.